In Focus
›
Stories
Hearing on Gilead's patent for hepatitis C drug, sofosbuvir, begins at patent office
Impact Stories
Related News & stories
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Conflict/Violence
Refugees and Migrants
News & Stories |
Jul 31, 2026 |
Eastern Chad: One in five pregnant women malnourished amid critical funding cuts
Noma
News & Stories |
Jul 31, 2026 |